Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patients

Fig. 4

Kaplan Meier Curves for IO Score, PD-L1 IC2/3, and Combined Dual-Positive Cases A Kaplan Meier curves for IO Score with HR and OS results; B Kaplan Meier curves for IC2/3 with HR and OS results; C Kaplan Meier curves for combined analysis of IO Score-positive AND IC2/3-postive cases with HR and OS results. Dual positive patients had a median OS of 17. 8 months compared to 12.8 (difference of 4.9 months) and an HR of 0.48 compared to 0.62. D Summary statistics for IO for the three Kaplan–Meier estimates

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us